Trademark Overview
On Thursday, February 22, 2024, a trademark application was filed for EVEREST MEDICINES with the United States Patent and Trademark Office. The USPTO has given the EVEREST MEDICINES trademark a serial number of 98416690. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 11, 2024. This trademark is owned by Everest Medicines (Singapore) Pte. Ltd.. The EVEREST MEDICINES trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:
Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; Pharmaceutical research; Pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; Pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; Pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in...
Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemical additives for use in the manufacture of medicines; Chemical substances for use in the production of drugs